PT936908E - Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela) - Google Patents

Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela)

Info

Publication number
PT936908E
PT936908E PT97931367T PT97931367T PT936908E PT 936908 E PT936908 E PT 936908E PT 97931367 T PT97931367 T PT 97931367T PT 97931367 T PT97931367 T PT 97931367T PT 936908 E PT936908 E PT 936908E
Authority
PT
Portugal
Prior art keywords
uteric
ela
treatment
lateral sclerosis
anticonvulsive
Prior art date
Application number
PT97931367T
Other languages
English (en)
Inventor
Richard P Shank
Original Assignee
Ortho Mcneil Corp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Corp Inc filed Critical Ortho Mcneil Corp Inc
Publication of PT936908E publication Critical patent/PT936908E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
PT97931367T 1996-06-28 1997-06-24 Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela) PT936908E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2200696P 1996-06-28 1996-06-28

Publications (1)

Publication Number Publication Date
PT936908E true PT936908E (pt) 2002-08-30

Family

ID=21807346

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97931367T PT936908E (pt) 1996-06-28 1997-06-24 Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela)

Country Status (22)

Country Link
US (1) US5753694A (pt)
EP (1) EP0936908B1 (pt)
JP (1) JP2000514426A (pt)
AP (1) AP1167A (pt)
AT (1) ATE214274T1 (pt)
AU (1) AU725093B2 (pt)
BR (1) BR9710993A (pt)
CA (1) CA2258892C (pt)
CZ (1) CZ293945B6 (pt)
DE (1) DE69711067T2 (pt)
DK (1) DK0936908T3 (pt)
ES (1) ES2176755T3 (pt)
HU (1) HUP9904318A3 (pt)
IL (1) IL127717A (pt)
NO (1) NO317136B1 (pt)
NZ (1) NZ333588A (pt)
PT (1) PT936908E (pt)
SI (1) SI0936908T1 (pt)
SK (1) SK284331B6 (pt)
UA (1) UA46112C2 (pt)
WO (1) WO1998000131A1 (pt)
ZA (1) ZA975764B (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985930A (en) * 1996-11-21 1999-11-16 Pasinetti; Giulio M. Treatment of neurodegenerative conditions with nimesulide
JP2003521471A (ja) 1999-04-08 2003-07-15 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 慢性神経変性疾患を処置することに有用な抗痙攣薬誘導体
US7553818B2 (en) * 1999-06-14 2009-06-30 Vivus, Inc. Combination therapy for effecting weight loss and treating obesity
CA2686633A1 (en) 1999-06-14 2000-12-21 Vivus, Inc. Combination therapy for effecting weight loss and treating obesity
US7056890B2 (en) 1999-06-14 2006-06-06 Vivus, Inc. Combination therapy for effecting weight loss and treating obesity
US20080255093A1 (en) * 1999-06-14 2008-10-16 Tam Peter Y Compositions and methods for treating obesity and related disorders
US7659256B2 (en) * 1999-06-14 2010-02-09 Vivus, Inc. Combination therapy for effecting weight loss and treating obesity
US7674776B2 (en) * 1999-06-14 2010-03-09 Vivus, Inc. Combination therapy for effecting weight loss and treating obesity
US20080103179A1 (en) * 2006-10-27 2008-05-01 Tam Peter Y Combination Therapy
US6191117B1 (en) * 2000-07-10 2001-02-20 Walter E. Kozachuk Methods of producing weight loss and treatment of obesity
EP1345602B1 (en) * 2000-11-30 2010-07-21 Novodermix International Limited Wound healing
RU2317086C2 (ru) * 2001-02-02 2008-02-20 Орто-Макнейл Фармасьютикал, Инк. Лечение неврологической дисфункции с применением сульфаматов фруктопиранозы и эритропоэтина
EP1450779A1 (en) * 2001-11-14 2004-09-01 Ralph Ryback Method for treating autoimmune diseases
US20060041022A1 (en) * 2002-11-06 2006-02-23 Pasinetti Giulio M Treatment of amyotrophic lateral sclerosis with nimesulide
EP1562570A4 (en) * 2002-11-06 2007-09-05 Sinai School Medicine TREATMENT OF AMYOTROPHER LATERAL SCLEROSIS WITH NIMESULID
US20050070524A1 (en) * 2003-06-06 2005-03-31 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and an anticonvulsant agent for the treatment of central nervous system disorders
TW200612905A (en) * 2004-06-16 2006-05-01 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
PE20060500A1 (es) * 2004-08-24 2006-07-13 Janssen Pharmaceutica Nv Derivados de heteroaril sulfamida benzo-fusionada como anticonvulsivantes
IS7748A (is) * 2005-03-17 2006-09-18 Actavis Group Samsetning fyrir töflur sem innihalda topiramate
WO2006127184A1 (en) * 2005-05-20 2006-11-30 Janssen Pharmaceutica N.V. Process for preparation of sulfamide derivatives
US20070155824A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives for disease modification / epileptogenesis
AR058389A1 (es) * 2005-12-19 2008-01-30 Janssen Pharmaceutica Nv Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad
US8691867B2 (en) * 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8497298B2 (en) * 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8937096B2 (en) * 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US20070155827A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
US8716231B2 (en) * 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US20070155823A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
US20070191451A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-heteroaryl sulfamide derivatives as neuroprotective agents
US20070191474A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
US20070191460A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Disease Modification / Epileptogenesis
EA200870556A1 (ru) * 2006-05-19 2009-06-30 Янссен Фармацевтика Н.В. Комбинированная терапия в лечении эпилепсии и родственных расстройств
FR2903019A1 (fr) * 2006-06-30 2008-01-04 Univ Claude Bernard Lyon I Eta Utilisation d'un inhibiteur de l'anhydrase carbonique, pour la preparation d'un medicament destine a traiter des degenerescences du muscle squelettique
US20090247616A1 (en) * 2008-03-26 2009-10-01 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
US20090247617A1 (en) * 2008-03-26 2009-10-01 Abdel-Magid Ahmed F Process for the preparation of benzo-fused heteroaryl sulfamates
US20090304789A1 (en) 2008-06-09 2009-12-10 Thomas Najarian Novel topiramate compositions and an escalating dosing strategy for treating obesity and related disorders
US8580298B2 (en) * 2008-06-09 2013-11-12 Vivus, Inc. Low dose topiramate/phentermine composition and methods of use thereof
EP2340246A2 (en) 2008-06-23 2011-07-06 Janssen Pharmaceutica, N.V. Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) * 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US4792569A (en) * 1987-08-27 1988-12-20 Mcneilab, Inc. Anticonvulsant phenethyl sulfamates
US5384327A (en) * 1992-12-22 1995-01-24 Mcneilab, Inc. Anticonvulsant sorbopyranose sulfamates

Also Published As

Publication number Publication date
HUP9904318A2 (hu) 2000-05-28
SK284331B6 (sk) 2005-01-03
WO1998000131A1 (en) 1998-01-08
DE69711067T2 (de) 2002-09-19
HUP9904318A3 (en) 2001-02-28
EP0936908B1 (en) 2002-03-13
IL127717A0 (en) 1999-10-28
DK0936908T3 (da) 2002-05-27
ATE214274T1 (de) 2002-03-15
UA46112C2 (uk) 2002-05-15
CA2258892C (en) 2005-08-09
BR9710993A (pt) 2002-02-26
AP1167A (en) 2003-06-30
NO986054D0 (no) 1998-12-22
NZ333588A (en) 2000-07-28
CA2258892A1 (en) 1998-01-08
SI0936908T1 (en) 2002-12-31
EP0936908A1 (en) 1999-08-25
CZ427998A3 (cs) 1999-08-11
AU725093B2 (en) 2000-10-05
DE69711067D1 (de) 2002-04-18
NO317136B1 (no) 2004-08-23
AP9801428A0 (en) 1998-12-31
CZ293945B6 (cs) 2004-08-18
NO986054L (no) 1999-03-01
IL127717A (en) 2004-09-27
JP2000514426A (ja) 2000-10-31
AU3501097A (en) 1998-01-21
SK180698A3 (en) 2000-07-11
ZA975764B (en) 1998-12-28
US5753694A (en) 1998-05-19
ES2176755T3 (es) 2002-12-01

Similar Documents

Publication Publication Date Title
PT936908E (pt) Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela)
NO983266D0 (no) Distribuert Behandling
NO984431D0 (no) FremgangsmÕte for behandling av smerte
DE69718990T2 (de) Behandlungsgerät
NO992806D0 (no) Terapeutiske midler
DK0799819T3 (da) 1-Dimethylaminomethyl-2-phenylcycloalk-2-enforbindelser med analgesisk virkning
DE69733470D1 (de) Laserbearbeitung
NO993066D0 (no) Ny behandling for leddinflammasjon
IS4898A (is) Sáraumbúðir
DE69807225D1 (de) Vliesstoffbehandlung
DE19681419T1 (de) Behandlungssystem
ZA978639B (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections.
NO983263L (no) Distribuert behandling
NO984446D0 (no) FremgangsmÕte for behandling av smerte
IS4789A (is) Meðferðarefnasambönd
BR9610382A (pt) Composição de tratamento do cableo
NO991158L (no) FremgangsmÕte for behandling av amyotrofisk lateralsklerose
ID16924A (id) Metode perlakuan poliolefin
BR9702075A (pt) Derivados de uréida biologicamente ativos úteis no tratamento de esclerose múltipla
DE29601701U1 (de) Sicherheitsbandage
DE29612101U1 (de) Behandlungsliege
KR970053540U (ko) 침시술용 침관
KR950003749U (ko) 폐수 처리기
DE29614843U1 (de) Sicherheitsbandage
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia